NeuroPace, Inc., a medical device company focused on improving the lives of individuals with epilepsy, has announced that an abstract from its Post-approval Study of the RNS System will be presented ...

MOUNTAIN VIEW, Calif., Dec. 01, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, ...

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its RNS System and NeuroPace AI platform will be ...

“NeuroPace revolutionized epilepsy therapy in 2013 with the introduction of the world’s first closed-loop, brain-responsive neuromodulation system—the only device that applies brain-computer interface ...

MOUNTAIN VIEW, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced three-year ...

In November 2013, the RNS System (responsive neurostimulation; NeuroPace, Inc.) was approved by the US Food and Drug Administration (FDA) for the treatment of focal onset refractory epilepsy. Dileep ...

NeuroPace, Inc. today announced that results from its pivotal trial demonstrated the RNS® System, a novel investigational device that utilizes responsive brain neurostimulation, significantly reduced ...

GOOD LUCK TO YOU TONIGHT. A NEW WAY TO HEAL. THE MOST COMMON CHRONIC BRAIN DISEASE IN THE U.S. EPILEPSY. NEARLY 3 MILLION PEOPLE HAVE IT CAUSING DISRUPTIVE AND DANGEROUS SEIZURES. BUT NOW THERE IS A ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--NeuroPace, Inc., a Silicon Valley-based medical technology company, presented long-term clinical results demonstrating that the RNS ® System for refractory ...

MOUNTAIN VIEW, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- December 4, 2024 – NeuroPace, Inc. (NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today ...

MOUNTAIN VIEW, Calif., December 02, 2025--(BUSINESS WIRE)--NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced ...